Drug intelligence / Profile preview

Zicam Ultra RapidMelts

Development stage
Unknown
Lead developer
Church & Dwight
Modality
Small Molecules
Administration
Oral
01

Overview

Zicam Ultra RapidMelts is an over-the-counter homeopathic cold remedy developed by Matrixx Initiatives (acquired by Church & Dwight in 2020). Formulated as sugar-free, dye-free quick-dissolve oral tablets, the product contains two active zinc salts: zinc acetate (Zincum aceticum) and zinc gluconate (Zincum gluconicum). It is indicated to shorten the duration of the common cold and help relieve nasal congestion when taken at the first sign of symptoms. The therapeutic effect is mediated by free ionic zinc (Zn2+) released in the oral-pharyngeal cavity, which binds to intercellular adhesion molecule 1 (ICAM-1) on epithelial cells, thereby competitively blocking rhinovirus attachment and entry, while also suppressing local inflammation.

Brand names
Zicam Cold Remedy Ultra RapidMeltsZicam Ultra RapidMelts
Other names
zinc acetate + zinc gluconatezincum aceticum + zincum gluconicum
02

Targets

ICAM1 (Intercellular Adhesion Molecule 1)

Beyond the preview

Go deeper on Zicam Ultra RapidMelts.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zicam Ultra RapidMelts.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call